Efforts to improve the delivery of hemodialysis have focused mostly on identifying patient-related factors that lead to inadequate dialysis. Less consideration has been given to the impact of the dialysis center on adequacy. This study evaluated whether the dialysis facility or individual-level factors were the primary influence on variations in dialysis adequacy. This was a retrospective analy...

BACKGROUND Stroke is the third leading cause of cardiovascular mortality in dialysis patients. The objective of this study was to assess the extent of stroke in chronic hemodialysis patients. METHODS Historical cohort of patients enrolled in two hemodialysis (HD) centers from January 1, 2010 to December 31, 2011, including 191 patients (mean age 52 years, 68% men). Incidence curves and surviv...

The Education Ambassadors program was established in 2008 by the International Society of Nephrology (ISN). To push new projects, skills, or services, community-based research, screening programs, Renal centers throughout world can submit an application to Educational (EA) Program receive professional assistance and hands-on training. ISN ambassadors provide guidance on clinical cases studies p...

INTRODUCTION Since the Beijing Hemodialysis Quality Control and Improvement Center was established in 2002, some registration work on hemodialysis (HD) has been done. We report here the current status of HD in Beijing, the capital of China. METHODS Data collection forms were distributed to all HD centers in Beijing, and data from 2003 and 2004 were collected for analysis of incidence, prevale...

Aim: The major cause of chronic renal disease (CRD) is diabetes mellitus (DM). Although there are some other long term glycemic markers available, HbA1c remains the gold standart in CRD. In this study we aimed to explore relation between average predialysis glucose and levels. 
 Material Method: 101 diabetic hemodialysis patients from two centers were included study. Last 2 3 months’ level...

BACKGROUND Medicare beneficiaries without prescription drug coverage consistently fill fewer prescriptions than beneficiaries with some form of drug coverage due to cost. ESRD patients, who are disproportionately poor and typically use multiple oral medications, would likely benefit substantially from any form of prescription drug coverage. Because most hemodialysis patients are Medicare-eligib...

INTRODUCTION The quality of the life in patients requiring long term hemodialysis is directly proportional to the long-term patency of their vascular access. Basilic vein transposition for vascular access (BAVA) represents a suitable option for creating a tertiary native vascular access for hemodialysis on the upper extremities for patients requiring long term hemodialysis. The purpose of the s...

BACKGROUND Patients with chronic kidney disease (CKD) experience multiple complications including erectile dysfunction (ED). It involves more than 50% of patients on dialysis or transplant. In Africa, the true extent of ED in CKD is unknown although some studies have been done in this regard. OBJECTIVES This study aimed to determine the prevalence and identify risk factors of ED in patients o...

ESTABLISHING and maintaining reliable intravenous access for patients with chronic renal failure or end-stage renal disease presents special considerations unique to this patient population. These patients often present with complicated medical conditions requiring intravenous medical therapies; at the same time, there is a critical need to preserve the peripheral and central veins for future h...

BACKGROUND AND OBJECTIVES Recombinant human erythropoietin (epoetin) is used routinely to increase blood hemoglobin levels in patients with ESRD and anemia. Although lower doses of epoetin are required to achieve equivalent hemoglobin responses when administered subcutaneously rather than intravenously, standard practice has been to administer epoetin to patients on hemodialysis intravenously. ...